We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Flying Brand | FBDU | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
2.50 | 2.50 |
Top Posts |
---|
Posted at 07/7/2017 19:28 by hedgehog 100 yasX4 Jul '17 - 00:41 - 189 of 191 1 0"Your points are duly noted. I have laid out just some of the significant concerns that exist ... " YasX, A major concern of mine, and one which seems to have been missed by the prospectus, is the heavy reliance on non-recurring revenues. This means that a continual stream of new customers will be needed just to maintain sales at the same level ... which may be difficult once the 'low-hanging fruit' is exhausted. That's one reason why medical equipment companies tend to be lowly-rated compared to biotechs. Furthermore, the relatively small amount of money raised leaves little room for error, but experience tells me that the vast majority of start-ups do not meet their projections - maybe one in a hundred or so does. The company is targeting a penetration rate of 3 - 4% of the kidney stone market in the UK for StoneChecker in the first 12 months from launch, a level which it seems to regard as low. However, capturing even a few % of a market is pretty high, and can be challenging to achieve. Trevor Brown has shown that's he's prepared to back FBDU at 1.1p and 1.5p, but at the moment investors are being asked to pay about two or three times those prices, which looks too high given the risks. Speculative stocks like this can often boom for a while on newsflow before crashing back, so there may be money to be made here as a trading punt, but at the current price of 3.25p there are more attractive risk-reward ratios elsewhere. P.S. There is also a potential overhand from Peterhouse: "E.1 Total net proceeds / expenses The Net Proceeds of the Placing are approximately £416,562. The total expenses incurred (or to be incurred) by the Company in connection with Admission, the Acquisition and the Placing are approximately £184,688, however Peterhouse will be taking their commission of £41,250 and fees of £10,000 (which have been included in the total expenses figure) through the issue of Ordinary Shares at Admission." |
Posted at 20/1/2017 15:47 by stevehoops Flying Brands LimitedAppointment of Mr Vinod Kaushal Flying Brands Limited (the "Company" or "Flying Brands") announces the board appointment of Mr Vinod Kaushal as a Non-Executive Director of the Company, with immediate effect. Vinod is a well-seasoned healthcare industry executive with nearly 30 years' experience in predominantly commercial and general management roles. He has worked nationally, regionally and globally for a number of blue chip and SME companies. Having been part of the team which orchestrated the international launch of Losec®/Prilosec& Since leaving Big Pharma, Vinod has recently been focused on entrepreneurial activities with a number of successful SMEs in the Pharma/Healthcare space. With an impressive deal sheet to his name, Vinod has been involved in various IP and business acquisitions. His career has seen him relate to investors on several global stock exchanges and he is an accomplished external speaker. Vinod holds a BSc (Hons) in Biochemistry from Warwick University and a MBA from Henley Business School. Trevor Brown, CEO of Flying Brands, commented: "I am delighted that Vinod is joining the Board. I believe that Flying Brand's shareholders will benefit greatly from Vinod's extensive experience, gained from many years of successfully launching novel medical solutions and applications into the global market-place." Work continues on the acquisition of Stone Checker Software Limited, previously announced on the 30 June and the Board intends to update shareholders of progress in due course. End |
Posted at 17/10/2016 12:46 by clocktower Shows what they think about their small investors - clearly not a stuff as they have not even provided an update. |
Posted at 01/2/2016 07:36 by swizz ct - What is the conflict of interest you refer to?,Many directors hold multiple positions and certainly in a non-exec role it can be very beneficial to have the network and experience available to developing businesses,........G Interesting snippet that Dr Qu Li has now joined the main board at Peterhouse...a snippet below from their update today.... "During the year, the Company raised £500,000 from existing and new investors from the UK and Far East. The funds raised will be utilised for the further expansion of the business including acquisitions, joint-venture and new product developments." "In addition, Peterhouse is delighted to announce the appointment of Dr. Qu Li to the Board. Dr. Qu Li is the founder and Chairman of China Ventures Ltd, www.chinaventuresltd |
Posted at 01/9/2015 06:53 by ryan83 Riddler you really need to read the recent RNS's.They had £60k cash after disposing of ALL legacy assets leaving them an empty shell. then they set up the convertible loans as a source of cash to keep the company going upto £300k worth at 1.1p. Therefore if they need any of the £300k it turns into stock at 1.1p, just like the first notice of £25k. I think there is £259k of the convertible loan left. Therefore say the current mar cap is £300k, if all the convertible loans are converted and that can at 1.1p then the shares in issue will double, so £600k with £300k cash. However there are a couple of things, one bieng that Trevor Brown the CEO has stumped up £150k of them and a company he owns has stumped up another £125k for these convertible loans. This gives confidence on a few measures, 1) his interests are aligned with investors, 2)once converted they should be tightly held and not supplying the market 3) fact CEO is stumping up this cash suggests there is a plan. Gla |
Posted at 17/6/2015 14:04 by clocktower www.flyingbrands.co.The company is little more than a shell but has a new website that looks fresh and bright and sounds good but that's about it. Current share price stands at 1.75 -2p The direction it is headed in is yet to be revealed but the history of the new BoD looks interesting and worth reviewing. The company as it was previously has had many ups and downs but the best part that came out of it was Stanley Gibbons - the rest went to the dogs as the management lost the plot along with investors money, as the shares stumble along without direction. Details of Shares: hxxp://www.flyingbra Alloted: 28,073,735 units comprising one Ordinary Share (of £0.01 each) and one ‘A’ Ordinary Share No securities are held as treasury shares 59.18% of Flying Brands Limited units are not held in public hands There are no restrictions on the transfer of shares There are also convertible loans for £300k that can be issued at £0.011 (some of these have been converted) Others have been issued at £0.015 sp as of 15.52 on 05.05.16 - 3.50 - 4p |
Posted at 16/6/2015 10:41 by clocktower Very good opening to the site with sound, however there is a lack of info about the current share structure and terms of loan etc - all a bit murky until there is more clear cut info provided by the company for retail investors. |
Posted at 12/8/2010 11:12 by cockneyrebel "Broker Singer Capital Markets reckons Flying Brands now offers investors an exciting turnaround story with better long-term growth prospects. If the full-year dividend payout equates to 2.4p, the current yield would be 4pc, rising to 7 per cent next year."7% yield going forward then? CR |
Posted at 19/3/2010 13:59 by interceptor2 I brougt Investors Chronicle this morning and read the Share mag article on fbdu while in the shop.Share mag have a buy rating at 70p and are very bullish. As well as continued recovery they say that a possibility is that Sir Tom Hunter whos takeover approach was rejected in November 2008, may bid again now that fbdu are on a firmer footing. His investment vehicle (West coast) still owns 29.9% I believe. (I wouldn't disagree) Investors Chonicle have the headline (Turnaround at Flying Brands) Sorry I'm not going to write the whole article because on the laptop this week and hate using the keyboard, but the sentiment is positive, and they acknowledge the progress that has been achieved and sum up as follows. "The UK flower delivery market is worth an estimated £500m a year and management is putting the business on a firmer footing. So while the shares are worth keeping an eye on, they're fairly priced." |
Posted at 18/3/2010 16:18 by interceptor2 Might be an article in Investors Chonicle tomorrow, I will buy one tomorrow and let you know. |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions